Rare diseases
Investigational molecules
Locations
The Schrodinger Building, Suite A Second Floor, Heatley Road, OX4 4GE, United Kingdom
Oxford Biotherapeutics Limited focuses on recurrent and metastatic solid tumors with CD205-positive disease expression, including gastric cancer, non-small cell lung cancer, endometrial cancer, and ovarian cancer.
The sponsor’s clinical activity is centered on cancers with advanced disease burden across multiple tumor origins.
Oxford Biotherapeutics Limited runs clinical trials in conditions such as Neoplasm malignant, among others.
Clinical trials run by this sponsor – those enrolling participants first.
BelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
